Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Cholesterol-Lowering Drugs May Lack Statins' Side Effects

By LabMedica International staff writers
Posted on 17 Mar 2011
A new generation of cholesterol-lowering drugs may be based on inhibitors of the enzyme squalene monooxygenase.

The current drugs of choice for reducing cholesterol levels, the statins, act by blocking the activity of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR). More...
Although statins are quite effective at reducing cholesterol, they are associated with potentially severe side effects such as intense muscle pain. These side effects may be due to the fact that blocking HMGR disrupts cholesterol production very early in the metabolic process. Squalene monooxygenase, on the other hand, forms a checkpoint much farther down the pathway where it uses NADPH and molecular oxygen to oxidize squalene to 2,3-oxidosqualene (squalene epoxide). At this point, it catalyzes the first oxygenation step in sterol biosynthesis, and is thought to be one of the rate-limiting enzymes in this pathway.

Another important point stressed in a paper published in the March 1, 2011, issue of the journal Cell Metabolism was that the activity of squalene monoxygenase was regulated by cholesterol itself and not by reaction byproducts or cofactors.

"Cholesterol has developed something of a bad name; so many people do not realize that it is actually essential for a healthy body. It is needed, for example, to make sex hormones and to help build the walls of every single cell in our bodies,” said senior author Dr. Andrew Brown, professor of biotechnology and biomolecular sciences at the University of New South Wales (Sydney, Australia). "The class of drugs most commonly used to lower cholesterol - statins – are the blockbusters of the pharmaceutical world and work by inhibiting HMGR. But HMGR is involved very early on in the assembly line, so inhibiting it affects all the other steps down the line – and other useful products it provides - and that can give rise in some people to unwanted side-effects, such as muscle pain.”

"What is exciting about this previously overlooked squalene monooxygenase enzyme is that it acts as a checkpoint much further down the assembly line, which should mean that it can be more specifically targeted at cholesterol production instead and leave the early part of the assembly line undisturbed,” said Dr. Brown.

Related Links:
University of New South Wales






Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.